Barbara J.  Schwarzentraub net worth and biography

Barbara Schwarzentraub Biography and Net Worth

Director of CONMED

Ms. Schwarzentraub held various roles at Caterpillar, Inc. from 1990 through 2020, including serving as a Director and Divisional Chief Financial Officer for their Global Information Services Division from 2017 until February 2020. From 2016 through 2017, Ms. Schwarzentraub was the Director of Caterpillar’s Global Component Manufacturing and Supply Chain, having previously served as the Director of Caterpillar’s Parts Distribution and Vice President of Caterpillar Logistics Services Inc. from 2010 through 2016. She also served as the Director of Global Finance Transformation from 2006 through 2010. Prior to these roles, she held a number of positions of increasing responsibility within Caterpillar. Ms. Schwarzentraub received her Master of Business Administration and Bachelor of Science in Accounting from Bradley University. The Board of Directors has determined that Ms. Schwarzentraub is independent within the meaning of the rules of the New York Stock Exchange, and that she is an audit committee financial expert within the meaning of the rules of the Securities and Exchange Commission.

Ms. Schwarzentraub’s qualifications for appointment to CONMED’s Board include her extensive experience in information technology and supply chain management on a global basis, experience in leading large organizations, financial and accounting experience, and recent experience in an active leadership position. The Board strongly believes that the Board and Company benefits from the perspectives that Ms. Schwarzentraub brings to the Board and the Company as a result of her business experience. She has the ability and willingness to serve on the Board, and the correct fit to work in a collegial manner with the other directors.

What is Barbara J. Schwarzentraub's net worth?

The estimated net worth of Barbara J. Schwarzentraub is at least $71,739.50 as of May 8th, 2024. Schwarzentraub owns 1,442 shares of CONMED stock worth more than $71,740 as of April 24th. This net worth estimate does not reflect any other assets that Schwarzentraub may own. Learn More about Barbara J. Schwarzentraub's net worth.

How do I contact Barbara J. Schwarzentraub?

The corporate mailing address for Schwarzentraub and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Barbara J. Schwarzentraub's contact information.

Has Barbara J. Schwarzentraub been buying or selling shares of CONMED?

Barbara J. Schwarzentraub has not been actively trading shares of CONMED over the course of the past ninety days. Most recently, on Wednesday, May 8th, Barbara J. Schwarzentraub bought 1,442 shares of CONMED stock. The stock was acquired at an average cost of $69.26 per share, with a total value of $99,872.92. Following the completion of the transaction, the director now directly owns 1,442 shares of the company's stock, valued at $99,872.92. Learn More on Barbara J. Schwarzentraub's trading history.

Who are CONMED's active insiders?

CONMED's insider roster includes Martha Aronson (Chair of the Board), Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Richard Glaze (Chief Information Officer), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Barbara Schwarzentraub (Director), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.

Are insiders buying or selling shares of CONMED?

In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 4,257 shares worth more than $304,074.95. The most recent insider tranaction occured on February, 11th when insider Richard Glaze sold 257 shares worth more than $16,794.95. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.

Information on this page was last updated on 2/11/2025.

Barbara J. Schwarzentraub Insider Trading History at CONMED

See Full Table

Barbara J. Schwarzentraub Buying and Selling Activity at CONMED

This chart shows Barbara J Schwarzentraub's buying and selling at CONMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50k$0$50kTotal Insider BuyingTotal Insider Selling

CONMED Company Overview

CONMED logo
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Read More

Today's Range

Now: $49.75
Low: $48.63
High: $51.11

50 Day Range

MA: $57.48
Low: $47.71
High: $63.09

2 Week Range

Now: $49.75
Low: $46.00
High: $78.58

Volume

608,842 shs

Average Volume

463,666 shs

Market Capitalization

$1.54 billion

P/E Ratio

11.73

Dividend Yield

1.67%

Beta

1.28